Capital at risk
Health Innovation
Healthcare is undergoing monumental change. Perhaps more than any other sector, it offers extreme payoffs for those seeking long-term disruptive investments. Companies developing technologies that improve outcomes for large numbers of patients can grow exponentially. Our quest is to own those rare firms for long periods while they transform the full value chain of human health.
Radical change, radical possibilities
The future of human health is radically changing. We aim to find and invest in companies that address society’s biggest problems to make healthcare more efficient and accessible and, in turn, generate strong long-term returns for our clients.
Health Innovation: our philosophy
Investment manager Julia Angeles introduces Health Innovation, reflecting on the exciting opportunities ahead.
Driving transformation
Our objective is to outperform the MSCI ACWI Index by at least 2.5 per cent (net of fees) over rolling five-year periods. We intend to achieve this by investing in companies that are driving the transformation of healthcare, from diagnosis and treatment to efficiency and access.
Our approach is agnostic to sector and benchmark composition. We aim to find and own those few companies that really matter in the theme and hold them in a concentrated portfolio of 25-50 names over the long term, generally for five years or more.
Different than the average
This is not just another healthcare sector fund. We are not restricted to the MSCI World Health Care Index – our opportunity set is much broader than that. This is a thematic fund. We are experiencing a great convergence of science and technology, and we are seeking the transformative companies at the heart of this.
That’s why we think we can offer something different. This approach isn’t new to Baillie Gifford. We have been investing in innovation since our inception in 1908, and today close to 15 per cent of our clients’ assets are invested in leading healthcare companies.
Most of the exorbitant costs of healthcare today are associated with care that is not transformative and not personalised. It’s clear that this model is unsustainable.
Meet the managers
Documents
Philosophy and process
Explore our investment process and idea generation as our Health Innovation investors believe it’s time to rethink what the term healthcare means.
Quarterly update
Get the latest investment commentary, portfolio overview, transactions and performance information alongside governance engagement and voting.
How to invest in this strategy
You can invest in this strategy through the following fund(s).
Invest through other vehicles
Get in touch to learn about the other ways to invest, including:
- Separate account
Strategy portfolio holdings
A list of the top 10 holdings that the representative portfolio invests in.
All figures up to: 31 August 2024
# | Holding | % of portfolio |
---|---|---|
1 | argenx | 7.3% |
2 | Alnylam Pharmaceuticals | 6.9% |
3 | ALK-Abello | 5.9% |
4 | Genmab | 5.1% |
5 | Ambu | 5.0% |
6 | Moderna | 4.4% |
7 | Novo Nordisk | 4.1% |
8 | ResMed | 4.0% |
9 | Insulet Corporation | 3.8% |
10 | Exact Sciences | 3.7% |
Please note
The information contained on this page is intended as a guide only and should not be relied upon when making investment decisions. All holdings information is unaudited. Source Baillie Gifford & Co. Please note that totals may not add due to rounding.
How to invest in this strategy
You can invest in this strategy through the following fund(s).
Invest through other vehicles
Get in touch to learn about the other ways to invest, including:
- Separate account
Insights
Key articles, videos and podcasts relating to the strategy:
Filters
Insights
AI: driving a new healthcare paradigm
Why AI could be key to us living longer and being in better health in the future.Health Innovation Q2 update
The Health Innovation Team reflects on recent performance, portfolio changes and market developments.Health Innovation Q1 update
The Health Innovation Team reflects on recent performance, portfolio changes and market developments.Five years of health innovation
Investors take note: technology and innovation are revolutionising treatments and patient care.Five years of the Health Innovation Strategy
A deep dive into five years of the Health Innovation Strategy and the progress made within healthcare.Moderna: designing drugs on a computer
Can scientists meet unmet health needs by writing code to help the body heal itself?Why growth, why now?
Tough times play to the partnership’s strengths: analysing what enables us to adapt and thrive amid rapid change.Health Innovation Strategy
Investment manager, Julia Angeles, discusses the Baillie Gifford Health Innovation Strategy.
Health Innovation Q2 update
The Health Innovation Team reflects on recent performance, portfolio changes and market developments.
AI: driving a new healthcare paradigm
Why AI could be key to us living longer and being in better health in the future.Health Innovation Q2 update
The Health Innovation Team reflects on recent performance, portfolio changes and market developments.Health Innovation Q1 update
The Health Innovation Team reflects on recent performance, portfolio changes and market developments.Five years of health innovation
Investors take note: technology and innovation are revolutionising treatments and patient care.Five years of the Health Innovation Strategy
A deep dive into five years of the Health Innovation Strategy and the progress made within healthcare.Moderna: designing drugs on a computer
Can scientists meet unmet health needs by writing code to help the body heal itself?Why growth, why now?
Tough times play to the partnership’s strengths: analysing what enables us to adapt and thrive amid rapid change.Health Innovation Strategy
Investment manager, Julia Angeles, discusses the Baillie Gifford Health Innovation Strategy.
How to invest in this strategy
You can invest in this strategy through the following fund(s).
Invest through other vehicles
Get in touch to learn about the other ways to invest, including:
- Separate account
How to invest in this strategy
You can invest in this strategy through the following fund(s).
Invest through other vehicles
Get in touch to learn about the other ways to invest, including:
- Separate account